Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

New clinical study on Multikine initiated in Canada

Sep. 12, 1997

Regressin induces apoptosis and direct inhibition of tumor cell growth

Sep. 12, 1997

Safety study of Multikine in prostate cancer patients completed

Sep. 10, 1997

Ribi seeks approval for melanoma vaccine in Canada

Sep. 9, 1997

Vical's Allovectin-7 enters phase II for head and neck cancer

Sep. 8, 1997

TNT nears clinical trials

Sep. 2, 1997

FDA requests additional manufacturing data before approval of Rituxan

Sep. 1, 1997

Dovetail issued patent for Betathine

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Theratope vaccine advances to phase III trials

Aug. 21, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...